Researcher identifies new biomarker of early-stage Alzheimer's disease

Researcher identifies new biomarker of early-stage Alzheimer's disease

University of New Mexico neurologist Rawan Tarawneh, MD, has identified a unique biomarker that could lead to new diagnostic tests to improve the detection of incipient Alzheimer's disease before symptoms appear.

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD, have been reported by G3 Therapeutics (Global Genomics Group) and Aitia. The findings imply that LDL-TG could be a novel diagnostic marker for ASCAD and could also open up potential novel treatment targets for atherosclerosis, focusing on triglyceride-rich LDL particles.